← All organizations

Kiadis Pharma

For profitWebsite ↗

Also known as: Kiadis Pharma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2021

Acquired by Sanofi-Aventis on Nov 2, 2020

Timeline

1990s

Jun 1, 1997
Kiadis Pharma— Founded

2000s

Jun 1, 2001
Celmed Biosciences— Acquired

2010s

Apr 17, 2019
CytoSen— Acquired

2020s

Nov 2, 2020
Sanofi-Aventis— Acquired By

Drugs by trial phase (11 distinct, 9 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

kds-1001

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (9)

NCT04808115CollaboratorPhase 1Oct 1, 2021
NCT04797975Lead sponsorPhase 1/Phase 2Dec 31, 2020
NCT04395092Lead sponsorPhase 2Jul 31, 2020
NCT02999854Lead sponsorPhase 3May 1, 2017
NCT02500550Lead sponsorPhase 2Oct 9, 2015
NCT01794299Lead sponsorPhase 2Mar 1, 2013
NCT00967343Lead sponsorPhase 2/Phase 3Aug 1, 2009
NCT00248404Lead sponsorPhase 1/Phase 2Sep 1, 2005
NCT00993486Lead sponsorPhase 1/Phase 2Jan 1, 2005

Details

Founded: Amsterdam, NL Jun 1, 1997
Last known activity: Oct 1, 2021